Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Bristol-Myers-Squibb
Company Monitoring Page for Bristol-Myers-Squibb
latest headlines for company on cafepharma
Tricks and Treats as Biopharma’s Q3 Earnings Season Gets Underway
BioSpace
Sun, 10/29/23 - 08:53 pm
Tags:
earnings
,
Bristol Myers Squibb
,
Takeda
,
Novartis
,
Sanofi
,
Merck
Bristol-Myers (BMY) Q3 Earnings & Sales Beat, Opdivo Sales Grow
Zacks.com
Thu, 10/26/23 - 10:58 pm
Tags:
Bristol Myers Squibb
,
earnings
Bristol Myers says it needs another year to hit target for new drugs
Reuters
Thu, 10/26/23 - 10:40 am
Tags:
Bristol Myers Squibb
,
Reblozyl
,
Sotyktu
,
Zeposia
BMS buys Asian rights to key growth drug Camzyos
Pharmaphorum
Wed, 10/25/23 - 09:46 am
Tags:
Bristol Myers Squibb
,
Asia
,
Camzyos
,
obstructive hypertrophic cardiomyopathy
Merck, BMS Score Separate Late-Stage Victories in Bladder Cancer at ESMO
BioSpace
Mon, 10/23/23 - 05:15 pm
Tags:
ESMO
,
Merck
,
Bristol Myers Squibb
,
bladder cancer
,
PD-1 inhibitors
,
Keytruda
,
Padcev
,
Opdivo
ESMO: Bristol Myers' Opdivo chalks up bladder cancer win. But a rival combo casts long shadow
Fierce Pharma
Sun, 10/22/23 - 06:06 pm
Tags:
ESMO
,
Bristol Myers Squibb
,
Opdivo
,
bladder cancer
,
Padcev
,
Keytruda
,
Merck
BMS, Halozyme score with subcutaneous version of Opdivo
Fierce Pharma
Thu, 10/19/23 - 10:42 pm
Tags:
Bristol Myers Squibb
,
Halozyme
,
Opdivo
,
clinical trials
Bristol Myers Squibb's Opdivo reign expands with new earlier-stage melanoma nod
Fierce Pharma
Mon, 10/16/23 - 11:45 am
Tags:
Bristol Myers Squibb
,
Opdivo
,
melanoma
,
FDA
Pfizer takes aim at BMS' first-in-class Zeposia with FDA nod for ulcerative colitis drug Velsipity
Fierce Pharma
Fri, 10/13/23 - 10:35 am
Tags:
Bristol Myers Squibb
,
Zeposia
,
Pfizer
,
Velsipity
,
etrasimod
,
ulcerative colitis
,
FDA
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
CP Wire/Businesswire
Sun, 10/8/23 - 06:16 pm
Tags:
Bristol Myers Squibb
,
M&A
,
Mirati Therapeutics
,
oncology
,
cancer
,
Krazati
Sun, 10/8/23 - 06:05 pm
Tags:
Bristol Myers Squibb
,
M&A
,
Mirati Therapeutics
,
oncology
Paradigm and Bristol Myers Squibb collaborate to build a new model for clinical trials
Drugs.com
Sun, 10/8/23 - 02:38 pm
Tags:
Paradigm Health
,
Bristol Myers Squibb
,
clinical trials
5 FDA decisions to watch in the fourth quarter
BioPharma Dive
Mon, 10/2/23 - 12:00 pm
Tags:
FDA
,
Alnylam
,
Onpattro
,
ATTR amyloidosis
,
Vertex Pharmaceuticals
,
CRISPR Therapeutics
,
exa-cel
,
Bluebird Bio
,
Zynteglo
,
sickle cell disease
,
Bristol Myers Squibb
,
2seventy bio
,
Abecma
,
Multiple Myeloma
,
Amgen
,
Lumakras
,
non-small cell lung cancer
,
Pfizer
,
estrasimod
,
ulcerative colitis
AstraZeneca, BMS Reluctantly Agree to Medicare Drug Price Negotiation Program
BioSpace
Wed, 09/27/23 - 11:57 am
Tags:
AstraZeneca
,
Bristol Myers Squibb
,
drug pricing
,
Inflation Reduction Act
,
Medicare
Latest trial win further supports expanded use of Bristol Myers’ Opdivo in lung cancer
BioPharma Dive
Sun, 09/24/23 - 08:54 pm
Tags:
Bristol Myers Squibb
,
Opdivo
,
non-small cell lung cancer
,
clinical trials
Samsung Biologics adds to BMS manufacturing partnership with new $242M antibody agreement
Fierce Pharma
Mon, 09/18/23 - 12:30 pm
Tags:
Samsung BioLogics
,
Bristol Myers Squibb
,
drug manufacturing
,
antibodies
Bristol Myers plans to double experimental treatments to expand research pipeline
Yahoo/Reuters
Thu, 09/14/23 - 11:19 am
Tags:
Bristol Myers Squibb
,
clinical trials
,
R&D
Xspray, seeking FDA approval for its Sprycel competitor, settles patent lawsuit with BMS
Fierce Pharma
Tue, 09/12/23 - 07:08 pm
Tags:
Xspray Pharma
,
FDA
,
Sprycel
,
Bristol Myers Squibb
,
Dasynoc
Bristol Myers Squibb reports results from Phase II study of BMS-986278
Clinical Trials Arena
Mon, 09/11/23 - 11:53 am
Tags:
Bristol Myers Squibb
,
clinical trials
,
progressive pulmonary fibrosis
,
BMS-986278
Bristol Myers accused of illegal tactics to keep Pomalyst monopoly in lawsuit
Reuters
Thu, 09/7/23 - 10:57 pm
Tags:
Bristol Myers Squibb
,
Celgene
,
patents
,
legal
,
Pomalyst
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
cafepharma is a: rock, tree, site
*
Fill in the blank.